Alongside the FDA’s orphan drug designation in the U.S., the European Commission’s orphan medicinal product designation for mitapivat underscores the urgent need for novel therapies for sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback